AFib Is 3 Times More Widespread Than Doctors Thought

Translate to Spanish or other 102 languages!

Previous studies have reported that about 3.3 million peopleTrusted Source in the United States have atrial fibrillation (AFib) — a condition that causes the heart to beat in an irregular pattern or very rapidly. Image for illustration purposes
Previous studies have reported that about 3.3 million peopleTrusted Source in the United States have atrial fibrillation (AFib) — a condition that causes the heart to beat in an irregular pattern or very rapidly. Image for illustration purposes
- Advertisement -

New research suggests that there may be more than 10.5 million people in the United States living with atrial fibrillation, that is, three times more cases than experts had previously estimated. Image credit: Keith Brofsky/Getty Images.

  • Previous studies have reported that about 3 million people in the United States have atrial fibrillation (AFib). 
  • Researchers from the University of California – San Francisco discovered that AFib is three times more common in the U.S. than previously thought.
  • Over the course of the study, scientists found that people with AFib tended to be younger, less likely to be female, and more likely to have high blood pressure and diabetes.

Follow the link to Medical News Today for the full story:

https://www.medicalnewstoday.com/articles/afib-is-3-times-more-widespread-than-doctors-thought

- Advertisement -

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

STHS Behavioral’s Summer Mental Health Tips for Kids

STHS Behavioral urges families to prioritize emotional well-being by maintaining routines, encouraging social connections and fostering growth beyond the classroom.

New Insight Into the Iron-Retention Strategies of Colorectal Cancer Cells

Mega Doctor News by Michigan Medicine - University of Michigan Newswise — ANN ARBOR, Michigan...

Study: Weight Loss Drugs Cut Risk of Four Cancers by Half or More

Medical News Today The use of glucagon-like peptide-1 (GLP-1) receptor agonistTrusted Source medications continues...

FDA Approves Expanded Use of Kidney Cancer Treatment Rooted in UTSW Discovery

Belzutifan, a first-in-class drug that arose from scientific discoveries at UT Southwestern Medical Center, has been approved by the Food and Drug Administration to treat some patients with earlier stage kidney cancers in combination with an immunotherapy drug. This move marks the latest expansion of belzutifan’s indications after it was originally approved in 2021.
- Advertisement -